
Core Banking Platform Stewardship
15+ years of zero incident core banking modernization for Germany's second largest bank.
Learn moreArtizent reimagined quality engineering across the product lifecycle for a Fortune 50 consumer goods leader with $84B+ in revenue and operations in 70+ countries, replacing manual sequential validation with an outcome based quality factory automating 95% of validation within CI/CD pipelines. Over a 7+ year engagement, release cycles compressed from 26 weeks to 8 weeks, operating costs fell 30%, and the client maintained zero compliance related incidents for three consecutive years.
Let’s TalkSequential testing across PLM, clinical/regulatory, and product data platforms queued every release manually, compressing competitive response time in an industry where shelf space is won or lost by weeks.
Replaced sequential manual testing with parallel automated quality gates, regression suites, and compliance checks across all systems. Human expertise reserved for the 5% requiring regulatory judgment, edge cases, and compliance exceptions.
Manual validation introduced human error risk at every handoff. One missed compliance check could trigger an FDA audit finding, a product recall, or a manufacturing halt, each with seven figure consequences.
FDA 21 CFR Part 11, FSMA traceability, and GMP standards enforced automatically at every quality gate. Human reviewers handle only the regulatory calls that automation cannot. Result: zero compliance incidents across three years of accelerated releases.
Product lifecycle, clinical/regulatory, and product data platforms operated as silos. Manual data synchronization created inconsistencies where a defect caught in one system might not propagate to connected platforms.
Governance framework connecting PLM, clinical/regulatory, and product data with automated lineage tracking. A defect caught in one system triggers appropriate checks across all connected platforms automatically.
Manual quality processes required dedicated engineers at every stage, with ongoing support overhead maintaining legacy testing infrastructure without a measurable path to cost reduction.
Automation of 95% of validation removed manual testing overhead at every stage. Operating costs for PLM, clinical, and product data platforms fell 30%, and ongoing support spend was cut by 50%, shifting budget from maintenance to improvement.
A 7+ year engagement structured in three phases: map and automate the compliance framework, build and integrate the quality factory into CI/CD pipelines, then shift to outcome based operations measuring velocity, compliance posture, and cost reduction.
Assessed validation processes across PLM, clinical/regulatory, and product data platforms to identify automation candidates. Mapped every quality gate to determine which checks automate (95%) and which require human regulatory judgment (5%). Designed the compliance framework ensuring FDA 21 CFR Part 11, FSMA, and GMP requirements are enforced through automation rather than manual oversight.
Implemented automated validation infrastructure within CI/CD pipelines. Built quality gates, regression suites, and compliance checks executing in parallel across previously siloed systems. Established a data governance framework connecting PLM, regulatory, and product data platforms with automated lineage tracking. Transitioned from sequential manual validation to parallel automated execution.
Shifted the engagement model from activity based to outcome based delivery. Quality engineering metrics tied directly to business results: release velocity, compliance posture, defect prevention, cost reduction. Continuous improvement cycle expanding automation coverage, identifying new edge cases for human review, and adapting to new product lines and regulatory requirements as the business evolves.
Engineering delivery across 7+ years plus quantified operational gains from cost reduction, support spend elimination, and defect prevention before manufacturing lines.
Release cycles compressed from 26 weeks to 8 weeks, putting products on shelf 18 weeks sooner in an industry where shelf position is measured in weeks.
Three consecutive years with zero compliance related production incidents across FDA, FSMA, and GMP regulated manufacturing while releasing faster than before.
Defects identified before reaching manufacturing lines, where remediation costs 10-100x more than pre production correction in regulated CPG environments.
“They didn't just automate our testing. They reimagined how quality engineering works across our entire product lifecycle. What used to take most of a year now takes weeks, and we have maintained a clean compliance record across every product release since. Their outcome based model means we measure what matters: products reaching market faster, manufacturing lines running clean, and regulatory confidence we can stake our reputation on.”

15+ years of zero incident core banking modernization for Germany's second largest bank.
Learn more
Unified Azure platform plus ML credit, fraud, and wealth intelligence.
Learn more
Radiant Logic consolidation and AI security automation for the world's largest asset manager.
Learn moreSee how Artizient can engineer AI into your mission critical systems.